secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulgent Genetics, Inc. (FLGT)
CIK:        0001674930
Form:       8-K
Filed at:   2025-05-02T23:59:59+00:00
Accession:  0000950170-25-062257
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fulgent Q1 core revenue $73.5M (+16% YoY); GAAP loss $0.37/share; reiterates FY25 guidance
--------------------------------------------------------------------------------

- Core revenue of $73.5M, up 16% YoY; GAAP net loss of $11.5M ($0.37 loss per share).
- Non-GAAP income of $1.2M ($0.04 per share); Adjusted EBITDA loss of $2.9M.
- Reiterates full-year 2025 core revenue guidance of $310M.
- Cash and investments $814.6M ($26.60 per share); repurchased ~516k shares for $8.7M in Q1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674930/000095017025062257/0000950170-25-062257-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674930/000095017025062257/flgt-20250502.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-062257

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer